Showing results (211-220 of 247) with videos related to
Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|August 30, 2023
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapiesLisa Hong, Dennis C Braden, Yaoning Zhao, et al.Cancer Research|October 29, 2021
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast CancerXuxu Gou, Meenakshi Anurag, Jonathan T Lei, et al.NPJ Breast Cancer|July 3, 2019
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtypeKevin M Levine, Nolan Priedigkeit, Ahmed Basudan, et al.Endocrinology|May 8, 2021
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer MetastasisRebecca J Watters, Kostas Verdelis, Peter C Lucas, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancerFederica Panebianco, Lindsey M Kelly, Pengyuan Liu, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancerSantiago Panesso-Gómez, Alexander J Cole, Alyssa Wield, et al.NPJ Breast Cancer|July 20, 2024
International survey on invasive lobular breast cancer identifies priority research questionsSteffi Oesterreich, Leigh Pate, Adrian V Lee, et al.Cancer Research|May 4, 2005
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptorJoan M Carboni, Adrian V Lee, Darryl L Hadsell, et al.Journal of the National Cancer Institute|October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancerDaniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.NPJ Breast Cancer|July 13, 2023
Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity?Jing Yu, Edaise M da Silva, Hae-Sun La, et al.Pageof 25